H B Fuller CompanyPricing actions lifted adjusted gross margin 200 bps and adjusted EBITDA 9%
H.B. Fuller is advancing its specialty materials strategy through deeper medical market exposure, strong aerospace and electronics demand, and pricing actions that offset inflation. The proposed acquisition of Advanced Medical Solutions would expand its total addressable market by $15 billion to $95 billion and supports a goal of exceeding 20% adjusted EBITDA margin by 2028. In Engineering Adhesives, organic growth was roughly 5% excluding the solar exit, with aerospace up 30% and electronics and general industries posting double-digit gains. Pricing increased net revenues by 3% in the fiscal second quarter, helping lift adjusted gross margin 200 basis points to 34.2% and adjusted EBITDA 9% to $181 million. However, volume remains a constraint, with flexible packaging soft, automotive down mid-single digits, and management guiding for low- to mid-single-digit volume declines in the second half. Shares have lost 7.2% year-to-date against a 15.7% rise for the industry.
H B Fuller CompanyPricing actions lifted adjusted gross margin 200 bps and adjusted EBITDA 9%
Avery Dennison Corp
Advanced Medical Solutions Group plcH.B. Fuller proposed acquisition of Advanced Medical Solutions, expanding TAM and supporting margin goals
3M Company